Indore SEZ exports jump 32 pc due to increased orders from pharma units

Exports from Indore’s Special Economic Zone (SEZ) jumped 32 percent to Rs 8,127.67 crore during the first seven months of the current financial year due to increased orders from pharmaceutical units, an official said on Monday.

According to an official from the Union Ministry of Commerce and Industry, the Indore SEZ, which houses factories manufacturing various products, exported Rs 8,127.67 crore from April-October in the current financial year.

He said in the previous financial year, exports from this SEZ from April to October were worth Rs 6,157.11 crore.

“About 70 percent of exports from the Indore SEZ are pharmaceuticals, and the United States is among the top importers of these drugs,” the official said.

He said the Indore SEZ, spread over 572 hectares in the Pithampur Industrial Area, houses 59 plants in various sectors, including pharmaceuticals, packaging materials, engineering, textile manufacturing, and food processing. Of these, 22 are in the pharmaceutical sector alone.

Related Posts

Licences of 20 medical stores suspended after inspections

Drug Control Department inspects 120 medical stores; 32 NDPS cases and 63 arrests recorded in 2026 so far The district administration has intensified action against illegal drug sale and distribution,…

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

NEW DELHI: Global investment firm Bain Capital has divested nearly a 1 per cent stake in Emcure Pharmaceuticals for over Rs 289 crore through open market transactions, according to the…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Licences of 20 medical stores suspended after inspections

Licences of 20 medical stores suspended after inspections

Bain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 crore

Bain Capital sells nearly 1 pc  stake in Emcure Pharma for Rs 289 crore

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

Sun Pharma to acquire U.S. firm Organon in $11.75 billion deal

HP accounts for 47 inferior drugs in March alert

HP accounts for 47 inferior drugs in March alert

Civil society group SAM calls for greater transparency involving clinical trials

Civil society group SAM calls for greater transparency involving clinical trials

Different packaging, typos expose fake Mounjaro racket

Different packaging, typos expose fake Mounjaro racket